Article summary
The European Commission has launched an open public consultation on the Pharmaceutical Strategy for Europe, which is in line with the Industrial Strategy for Europe. The strategy aims to ‘create a “future proof” system, which reaps the benefits of digitalisation and promotes innovation’, reduce the EU’s dependency on third-country imports, reduce the impact of medicines on the environment and address anti-microbial resistance. The consultation is open to anyone and closes on 15 September 2020. The consultation is made up of questions, which focus on key themes such as the manufacturing of medicines. The responses will contribute to the preparation of the Pharmaceutical Strategy, which is expected to be adopted by the end of 2020.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial